Inducible COX-2 Dominates Over COX-1 in Prostacyclin Biosynthesis: Mechanisms of COX-2 Inhibitor Risk to Heart Disease

Life Sciences - United States
doi 10.1016/j.lfs.2010.10.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

COX-1 and COX-2 in Health and Disease

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1999English

COX-1 and COX-2 Products in the Gut: Therapeutic Impact of COX-2 Inhibitors

Gut
Gastroenterology
2000English

Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis

Archives of Internal Medicine
2000English

Arachidonic Acid Oxygenation by COX-1 and COX-2

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Viscum Album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA

PLoS ONE
Multidisciplinary
2015English

COX-2 Protects Against Atherosclerosis Independently of Local Vascular Prostacyclin: Identification of COX-2 Associated Pathways Implicate Rgl1 and Lymphocyte Networks

PLoS ONE
Multidisciplinary
2014English

Over-Expression of COX-2 mRNA in Colorectal Cancer

BMC Gastroenterology
MedicineGastroenterology
2014English

Role of Cyclooxygenases COX-1 and COX-2 in Modulating Adipogenesis in 3t3-L1 Cells

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2002English

Novel COX-2 Inhibitor for Breast Cancer Therapy

2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy